TY - JOUR
T1 - Evaluation of Zoll Medicals ResQCPR System for cardiopulmonary resuscitation
AU - Debaty, Guillaume
AU - Metzger, Anja
AU - Lurie, Keith
N1 - Publisher Copyright:
© 2015 Informa UK, Ltd.
PY - 2015/9/3
Y1 - 2015/9/3
N2 - Cardiac arrest remains a leading cause of death, currently affecting more than 250,000 Americans annually. As recommended by the American Heart Association, the current standard of care for patients with an out-of-hospital cardiac arrest (OHCA) includes manual cardiopulmonary resuscitation (S-CPR). Survival with favorable neurological function for all patients following OHCA and treated with S-CPR averages <6%. The ResQCPR System is intended to provide greater circulation to the heart and brain compared with S-CPR, thereby increasing the likelihood of survival. A recent Phase III, multicenter randomized study demonstrated a 50% increase in survival to hospital discharge with favorable neurologic function in subjects with an OHCA of presumed cardiac etiology treated with the ResQCPR System compared with conventional CPR. The ResQCPR System has been recently approved by the FDA as a CPR adjunct to improve the likelihood of survival in adult patients with non-traumatic cardiac arrest.
AB - Cardiac arrest remains a leading cause of death, currently affecting more than 250,000 Americans annually. As recommended by the American Heart Association, the current standard of care for patients with an out-of-hospital cardiac arrest (OHCA) includes manual cardiopulmonary resuscitation (S-CPR). Survival with favorable neurological function for all patients following OHCA and treated with S-CPR averages <6%. The ResQCPR System is intended to provide greater circulation to the heart and brain compared with S-CPR, thereby increasing the likelihood of survival. A recent Phase III, multicenter randomized study demonstrated a 50% increase in survival to hospital discharge with favorable neurologic function in subjects with an OHCA of presumed cardiac etiology treated with the ResQCPR System compared with conventional CPR. The ResQCPR System has been recently approved by the FDA as a CPR adjunct to improve the likelihood of survival in adult patients with non-traumatic cardiac arrest.
KW - active compression decompression
KW - cardiac arrest
KW - cardiopulmonary resuscitation
KW - impedance threshold device
UR - http://www.scopus.com/inward/record.url?scp=84940537682&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84940537682&partnerID=8YFLogxK
U2 - 10.1586/17434440.2015.1081813
DO - 10.1586/17434440.2015.1081813
M3 - Review article
C2 - 26305836
AN - SCOPUS:84940537682
SN - 1743-4440
VL - 12
SP - 505
EP - 516
JO - Expert Review of Medical Devices
JF - Expert Review of Medical Devices
IS - 5
ER -